Hyperparathyroidism, Secondary
"Hyperparathyroidism, Secondary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
Descriptor ID |
D006962
|
MeSH Number(s) |
C19.642.355.480
|
Concept/Terms |
Hyperparathyroidism, Secondary- Hyperparathyroidism, Secondary
- Secondary Hyperparathyroidism
- Hyperparathyroidisms, Secondary
- Secondary Hyperparathyroidisms
|
Below are MeSH descriptors whose meaning is more general than "Hyperparathyroidism, Secondary".
Below are MeSH descriptors whose meaning is more specific than "Hyperparathyroidism, Secondary".
This graph shows the total number of publications written about "Hyperparathyroidism, Secondary" by people in this website by year, and whether "Hyperparathyroidism, Secondary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2017 | 5 | 1 | 6 |
2018 | 7 | 2 | 9 |
2019 | 3 | 0 | 3 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperparathyroidism, Secondary" by people in Profiles.
-
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021 Jul 26; 13(8).
-
Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics. BMC Surg. 2019 Jul 16; 19(1):94.
-
Vitamin D: A cardiovascular risk biomarker or a treatment target? Hellenic J Cardiol. 2019 Mar - Apr; 60(2):114-116.
-
Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk. Curr Vasc Pharmacol. 2019; 17(6):610-617.
-
Preoperative calcitriol reduces postoperative intravenous calcium requirements and length of stay in parathyroidectomy for renal-origin hyperparathyroidism. Surgery. 2019 01; 165(1):151-157.
-
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism. Blood Purif. 2019; 47(1-3):37-44.
-
[Hyperphosphatemia in dialysis: which binder?] G Ital Nefrol. 2018 Sep; 35(5).
-
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results. J Nephrol. 2018 Oct; 31(5):767-773.
-
[Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?] G Ital Nefrol. 2018 May; 35(3).
-
[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy]. G Ital Nefrol. 2018 May; 35(3).